Literature DB >> 10190119

Haemagglutination and haemolysis by oral Fusobacterium nucleatum.

E Gaetti-Jardim Júnior1, M J Avila-Campos.   

Abstract

Haemagglutination and haemolytic activity of 80 Fusobacterium nucleatum isolates from human and animal origin, on different human blood types was evaluated. All the isolates were able to agglutinate erythrocytes and the most were either alpha-haemolytic or beta-haemolytic. No specificity between haemolysin or haemagglutinin and blood type was observed. Haemagglutination activity was inhibited when D-galactose, D-lactose or D-raffinose were used. Haemagglutination and haemolysis may be important factors in the pathogenesis of human and animal periodontal diseases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10190119

Source DB:  PubMed          Journal:  New Microbiol        ISSN: 1121-7138            Impact factor:   2.479


  3 in total

1.  A cocoa (Theobroma cacao L.) extract impairs the growth, virulence properties, and inflammatory potential of Fusobacterium nucleatum and improves oral epithelial barrier function.

Authors:  Amel Ben Lagha; Patricia Maquera Huacho; Daniel Grenier
Journal:  PLoS One       Date:  2021-05-24       Impact factor: 3.240

2.  Tea polyphenols inhibit the growth and virulence properties of Fusobacterium nucleatum.

Authors:  Amel Ben Lagha; Bruno Haas; Daniel Grenier
Journal:  Sci Rep       Date:  2017-03-21       Impact factor: 4.379

3.  Fusobacterium Species and Subspecies Differentially Affect the Composition and Architecture of Supra- and Subgingival Biofilms Models.

Authors:  Thomas Thurnheer; Lamprini Karygianni; Manuela Flury; Georgios N Belibasakis
Journal:  Front Microbiol       Date:  2019-07-30       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.